Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

Starting soon · Phase 1/Phase 2

Conditions studied: Cancer, Cachexia

In brief

A study to evaluate the safety, tolerability, and preliminary efficacy of DS010 in patients with cancer and cachexia

Key facts

Study ID

NCT07530666

Run by

Dartsbio Pharmaceuticals Ltd.

People needed

58

Starts

2026-04-30

Expected to finish

2028-04-30

Last updated by the study team

2026-04-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Sun Yat-sen University Cancer Center — Guangzhou, Guangdong, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.